NCT00388596View on ClinicalTrials.gov

A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

October 31, 2006

Conditions

Osteoporosis

Interventions

DRUG

SB-751689

Trial Locations (1)

33169

GSK Investigational Site, Miami

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY